CKD-352
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 01, 2021
Study to Evaluate the Efficacy and Safety of CKD-352
(clinicaltrials.gov)
- P3; N=283; Completed; Sponsor: Chong Kun Dang Pharmaceutical; Recruiting ➔ Completed; Trial primary completion date: Nov 2020 ➔ May 2021
Clinical • Trial completion • Trial primary completion date • Dry Eye Disease • Ophthalmology
September 14, 2020
Study to Evaluate the Efficacy and Safety of CKD-352
(clinicaltrials.gov)
- P3; N=280; Recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P3 trial • Dry Eye Disease • Ocular Infections • Ophthalmology
1 to 2
Of
2
Go to page
1